Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Titel:
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Auteur:
Horwitz, Steven M. Scarisbrick, Julia J. Dummer, Reinhard Whittaker, Sean Duvic, Madeleine Kim, Youn H. Quaglino, Pietro Zinzani, Pier Luigi Bechter, Oliver Eradat, Herbert Pinter-Brown, Lauren Akilov, Oleg E. Geskin, Larisa Sanches, Jose A. Ortiz-Romero, Pablo L. Weichenthal, Michael Fisher, David C. Walewski, Jan Trotman, Judith Taylor, Kerry Dalle, Stephane Stadler, Rudolf Lisano, Julie Bunn, Veronica Little, Meredith Prince, H. Miles